Thursday, July 28, 2022

You’re invited: Webinars on atopic dermatitis and severe asthma

Having trouble viewing this message? View this email in a browser.
Share Share
Tweet Tweet
Forward Forward

New Webinars on Atopic Dermatitis and Severe Asthma

The Asthma and Allergy Foundation of America (AAFA) has joined with PlatformQ Health and MedLive to offer you two new educational programs on atopic dermatitis and severe asthma. Sign up below!

ATOPIC DERMATITIS

Join us for the educational program, "It Isn't Just Skin: the Ins and Outs of Moderate-to-Severe Atopic Dermatitis." The live, interactive session will take place on Aug. 4 at 9 a.m. ET.
REGISTER NOW
During this one-hour program, two dermatologists, a patient, and a representative from AAFA will discuss:
  • Causes of atopic dermatitis
  • Symptoms and triggers of atopic dermatitis
  • Treatment options
  • Managing related conditions
  • Importance of clinical trials, particularly with diverse participants 
This program will help you learn more about managing atopic dermatitis and help you take a more active role in creating your treatment plan.
 
If you miss the live session, you can watch it later on demand. 
 
Have questions about atopic dermatitis? The panel will answer questions from the audience during the session. Submit your questions now until the start of the webinar.

SEVERE ASTHMA

Join us for "Breathe Easier with Severe Asthma: the Role of Current and Future Therapies in Reducing Exacerbations and Gaining Control of Your Symptoms." The live, interactive session will take place on Aug. 15 at 6 p.m. ET.
REGISTER NOW
During this one-hour program, two doctors, a patient, and a representative from AAFA will discuss the multiple factors involved in asthma inflammation. Other topics include:
  • How to reduce asthma triggers in your home
  • Types of asthma
  • Treatment options and side effects, including biologics
  • Strategies to communicate treatment goals to your health care providers 
If you miss the live session, you can watch it later on demand. 
 
Have questions about severe asthma? The panel will answer questions from the audience during the session. Submit your questions now until the start of the webinar.

New Live CME Programs for Health Care Professionals


We also have two new live CME programs for health care professionals who treat patients with severe asthma or atopic dermatitis. 
 

Severe Asthma

Join us for "Biologic Therapy for Patients with Severe Asthma: Impeding the Inflammatory Cascade" on Aug. 23 at 6 p.m. ET.

An expert panel of clinicians and patient representatives will talk about:
  • Roles of various inflammatory pathways in severe asthma
  • Mechanisms of action of various therapies and their safety and efficacy data
  • How a new treatment option targeting TSLP can be integrated into asthma management plan

Panelists will share strategies to identify patients most likely to benefit from current and emerging therapies and select the most appropriate biologic.

Register now to watch it live. If you miss the live session, you can watch it later on demand.
 

Moderate-to-Severe Atopic Dermatitis

Coming this fall: "Disparity and Equity in Moderate-to-Severe AD Care: Enhancing Access to Multidisciplinary Care for Patients from Diverse Populations." Watch for more details!

Thank you for your continued support.
Visit aafa.org and kidswithfoodallergies.org

FOLLOW US:
Facebook Facebook
Twitter Twitter
Instagram Instagram
YouTube YouTube
TikTok TikTok
LinkedIn LinkedIn
Disclaimer: This newsletter is provided to you as a member and subscriber benefit and your use of it is in accordance with our website's terms of service.

Asthma and Allergy Foundation of America makes no representation, whatsoever, for the contents that may be contained in any of the sponsors or advertisers in this newsletter or the quality of any products, information, or other materials displayed, purchased or obtained by you as a result of an offer in connection with any advertisement. 

Please follow the instructions at the bottom of the newsletter to unsubscribe if you no longer wish to be on our newsletter mailing list. This newsletter is sent to all newsletter subscribers, registered members and donors of Asthma and Allergy Foundation of America.

Copyright © 2022 Asthma and Allergy Foundation of America, All rights reserved. ISSN 1939-8166.

Important notice: We will never sell, rent or trade your e-mail address to any other organization. Please see our Privacy Policy.






This email was sent to edwardlorilla2001.tower2@blogger.com
why did I get this?    unsubscribe from this list    update subscription preferences
Asthma and Allergy Foundation of America · 1235 S Clark St · Suite 305 · Arlington, VA 22202 · USA

No comments:

Post a Comment